Michael Ball

Michael Ball

Chief Executive Officer

Mr. Ball is a pioneer in genomics informatics with a history of scaling global companies from startup through acquisition and IPO. Most recently, Mr. Ball served as the Global Vice President of Informatics, Commercial, at Illumina, Inc. (NASDAQ: ILMN), where he led the post-acquisition integration of GenoLogics, a venture capital-backed startup. At Illumina, Mr. Ball built a global commercial informatics team to sell and support Illumina’s emerging informatics portfolio. Previously, as GenoLogics’ Chief Executive Officer, Mr. Ball successfully led GenoLogics from startup through commercialization and exit, creating a market-leading business in Lab Information Management Systems for genomics. Before becoming CEO of GenoLogics, Mr. Ball held roles as Vice President Sales & Support for EMEA, and later, as Vice President Business Development at Creo Products, Inc. During this time, Creo became a world leader in computer-to-plate imaging systems. Mr. Ball holds a Bachelor of Commerce, with Marketing and Computer Science specializations, from the University of British Columbia.